Stocks
Applied Therapeutics (APLT) EV/EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| EV/EBITDA | ? | -6.87 | -4.11 | -1.42 | 0.01 | -3.61 | 0.69 | |
| Changes by years, y/y, % | -587% | -40% | -65% | -101% | -31 578% | |||
Applied Therapeutics. EV/EBITDA
Applied Therapeutics. EV/EBITDA, changes, %
Applied Therapeutics (APLT) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -3.50 | -4.48 | -3.06 | -1.39 | -0.28 | 0.69 | |
| Changes by years, y/y, % | -174 098% | +4 562% | +821% | +19% | -92% | |||
| Changes by quarters, q/q, % | +201% | +28% | -32% | -55% | -80% | |||
